Assessment of immunogenicity and safety of yellow fever vaccination in HIV-infected patients : a pilot study
Yellow fever (YF) is an acute haemorrhagic fever with a case fatality rate of 15-50 percent. It can effectively be prevented by the administration of a live-attenuated 17D yellow fever vaccine.
|